Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic
Michael A Veronin,1 Robert P Schumaker,2 Rohit R Dixit,2 Harshini Elath21Social and Administrative Sciences, Department of Pharmaceutical Sciences, University of Texas at Tyler, Ben and Maytee Fisch College of Pharmacy, Tyler, TX 75799, USA; 2Department of Computer Science, College of Business and T...
Main Authors: | Veronin MA, Schumaker RP, Dixit RR, Elath H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Drug, Healthcare and Patient Safety |
Subjects: | |
Online Access: | https://www.dovepress.com/opioids-and-frequency-counts-in-the-us-food-and-drug-administration-ad-peer-reviewed-article-DHPS |
Similar Items
-
Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
by: Risako Hirai, et al.
Published: (2023-11-01) -
Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data
by: Guowen Feng, et al.
Published: (2023-01-01) -
Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
by: Feng Huang, et al.
Published: (2024-03-01) -
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
by: Fan Zou, et al.
Published: (2023-12-01) -
Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
by: Shihao Chen, et al.
Published: (2024-03-01)